<DOC>
	<DOCNO>NCT02723396</DOCNO>
	<brief_summary>Sleep benefit ( SB ) prominent spontaneous , apparently unpredictable , transitory improvement motor function report around 50 % patient affect Parkinson 's Disease ( PD ) sleep take first dose dopaminergic medication . This study aim systematically characterize SB PD patient ecological set explore relationship nocturnal diurnal sleep subjective objective measure motor function . A good understanding phenomenon mandatory future research topic .</brief_summary>
	<brief_title>Sleep , Awake &amp; Move - Part I</brief_title>
	<detailed_description>The `` Sleep &amp; Move '' study first part Sleep , Awake &amp; Move project . In observational study plan systematically investigate SB day-to-day variation phenomenon PD patient prospective , repeat assessment 14 day subjective objective measure motor function sleep patient ' home , Android app develop ad hoc .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Diagnostic criterion idiopathic Parkinson 's disease ( UKPDBB ) Mild moderate disease ( Hoehn &amp; Yahr score ≥ 1 &lt; 3 ) Mentally physically capable give inform consent Stable antiparkinsonian psychotropic therapy last 30 day Atypical parkinsonian syndrome Cognitive impairment ( MMSE ≥ 26 ) Deep brain stimulation History cerebrovascular disease , epilepsy , disable neurological disease Psychiatric disorder , except mild depression ( BDI score &lt; 14 ) Alcohol abuse Other clinically significant severe concomitant disease state Inability follow procedure study ( e.g . due language problem , psychological disorder , etc . ) Participation another study investigational drug within 60 day precede present project .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Sleep Benefit</keyword>
</DOC>